Advertisement One week ago, the FDA approved the updated versions for Pfizer/BioNTech and Moderna, an mRAN. They are now available in some pharmacies. All these vaccines include a monovalent ...

1 strain of the virus. "Today's authorization provides an additional COVID-19 vaccine option," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. Doses are on ...

Both Pfizer and Moderna’s shots target the KP.2 COVID-19 variant—JN.1 is the parent variant of KP.2. The FDA in June asked vaccine makers to create shots that target the coronavirus’ JN.

The Pfizer and Moderna recipes are tailored to a virus subtype called KP.2. The Novavax formula targets its parent strain, called JN.1. The FDA considers both closely enough related to currently ...

The FDA argues research shows that regardless of appearance, customers' ages are difficult for retailers to accurately discern from looks alone. Advertisement It further mandates that also ...

The FDA’s Center for Drug Evaluation and Research (CDER) is consolidating its artificial-intelligence-related activities under a single AI Council, in part in response to efforts from the Biden ...

After the U.S. Food and Drug Administration (FDA) approved the emergency use of the 2024-2025 COVID-19 vaccines many questions are beginning to circulate. In the FDA's press release on Aug. 22 ...

Here’s your first look at Angelina Jolie in Pablo Larraín’s latest Venice-bound biopic Maria. Larraín directs the film from a screenplay by Steven Knight (Peaky Blinders). The pair ...

Democratic Reps. Ayanna Pressley of Massachusetts and Shontel Brown of Ohio pressed the FDA in a letter to finalize the proposed rule for banning certain salon-grade and at-home hair straighteners.

Newly formulated COVID-19 vaccines from Moderna and Pfizer just received their okay from the U.S. Food and Drug Administration (FDA). They should be available to the public by Labor Day.

"Vaccination continues to be the cornerstone of COVID-19 prevention," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research. KP.2 is no longer dominant but is still ...